Imagen de Portada
Código QR

PARP Inhibitors in Ovarian Cancer: A Review.

Publicado en:Targeted Oncology Vol. 18; no. 4; pp. 471 - 504
Autores principales: O'Malley, David M., Krivak, Thomas C., Kabil, Nashwa, Munley, Jiefen, Moore, Kathleen N.
Formato: Journal Article
Publicado: Springer Nature Jul2023
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=164899847&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 164899847
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        17762596
        47DQ
      jtl: Targeted Oncology
      issn: 17762596
      maglogo: N
    pubinfo:
      dt: Jul2023
      vid: 18
      iid: 4
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        164899847
        164039906
        10.1007/s11523-023-00970-w
        164899847
      ppf: 471
      ppct: 33
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: PARP Inhibitors in Ovarian Cancer: A Review.
      aug:
        au:
          O'Malley, David M.
          Krivak, Thomas C.
          Kabil, Nashwa
          Munley, Jiefen
          Moore, Kathleen N.
        affil: Division of Gynecology Oncology, The Ohio State University Comprehensive Cancer Center, James Cancer Hospital and Solove Research Institute, Columbus, OH, USA
      sug:
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N